The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • No ClinVar Id was directly found from the curated document
  • ClinVar Id was derived from the Allele Registry.
  • No CSPEC related information was provided by the message!

  • See Evidence submitted by expert panel for details.

Variant: NM_001306179.2:c.58G>C

CA386952573

1327599 (ClinVar)

Gene: HNF1A
Condition: monogenic diabetes
Inheritance Mode: Autosomal dominant inheritance
UUID: 7d6401b1-eb48-47e6-bb85-5d49afa7a19f
Approved on: 2021-08-18
Published on: 2021-10-29

HGVS expressions

NM_001306179.2:c.58G>C
NC_000012.12:g.120978826G>C
CM000674.2:g.120978826G>C
NC_000012.11:g.121416629G>C
CM000674.1:g.121416629G>C
NC_000012.10:g.119901012G>C
NG_011731.2:g.5081G>C
ENST00000257555.11:c.58G>C
ENST00000257555.10:c.58G>C
ENST00000400024.6:c.58G>C
ENST00000402929.5:n.193G>C
ENST00000535955.5:n.42+134G>C
ENST00000538626.2:n.176G>C
ENST00000538646.5:c.58G>C
ENST00000540108.1:c.58G>C
ENST00000541395.5:c.58G>C
ENST00000541924.5:c.58G>C
ENST00000543427.5:c.58G>C
ENST00000544413.2:c.58G>C
ENST00000544574.5:c.58G>C
ENST00000560968.5:n.201G>C
ENST00000615446.4:c.-258+115G>C
ENST00000617366.4:c.58G>C
NM_000545.5:c.58G>C
NM_000545.6:c.58G>C
NM_001306179.1:c.58G>C
NM_000545.8:c.58G>C
NM_000545.8(HNF1A):c.58G>C (p.Gly20Arg)
More

Likely Pathogenic

Met criteria codes 4
PM1_Supporting PS1 PP3 PM2_Supporting
Not Met criteria codes 2
PS4 PM5

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Monogenic Diabetes VCEP
The c.58G>C variant in the HNF1 homeobox A gene, HNF1A, causes an amino acid change of glycine to arginine at codon 20 (p.(G20R)) of NM_000545.8. This variant is located within the dimerization domain (codons 1-32) of HNF1A, which is defined as critical for the protein’s function by the ClinGen MDEP (PM1_Supporting). This variant is predicted to be deleterious by computational evidence, with a REVEL score of 0.956, which is greater than the MDEP threshold of 0.70 (PP3). This variant is absent in gnomAD v2.1.1 (PM2_Supporting) and was identified in two unrelated individuals with non-autoimmune and non-absolute/near-absolute insulin-deficient diabetes; however, PS4_Moderate cannot be applied because this number is below the ClinGen MDEP threshold (internal lab contributors). The nucleotide change c.58G>A, which causes the same amino acid change, has been classified as pathogenic for monogenic diabetes by the ClinGen MDEP (PS1). Two other missense variants, c.59G>A (p.Gly20Glu) and c.59G>C (p.Gly20Ala) do not meet the criteria for likely pathogenic or pathogenic without the supporting evidence of PM5; therefore, PM5 will not be applied. Taken together, the evidence supports the classification of this variant as likely pathogenic for monogenic diabetes. ACMG/AMP criteria applied, as specified by the ClinGen MDEP VCEP (specification version 1.0): PS1, PP3, PM1_Supporting, PM2_Supporting.
Met criteria codes
PM1_Supporting
This variant is located within the dimerization domain (codons 1-32) of HNF1A, which is defined as critical for the protein’s function by the ClinGen MDEP (PM1_Supporting).
PS1
The nucleotide change c.58G>A, which causes the same amino acid change, has been classified as pathogenic for monogenic diabetes by the ClinGen MDEP (PS1).
PP3
This variant is predicted to be deleterious by computational evidence, with a REVEL score of 0.956, which is greater than the MDEP threshold of 0.70 (PP3).
PM2_Supporting
This variant is absent in gnomAD v2.1.1 (PM2_Supporting)
Not Met criteria codes
PS4
This variant was identified in two unrelated individuals with non-autoimmune and non-absolute/near-absolute insulin-deficient diabetes; however, PS4_Moderate cannot be applied because this number is below the ClinGen MDEP threshold (internal lab contributors).
PM5
Two other missense variants, c.59G>A (p.Gly20Glu) and c.59G>C (p.Gly20Ala) do not meet the criteria for likely pathogenic or pathogenic without the supporting evidence of PM5; therefore, PM5 will not be applied.
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.